Almay Clear Complexion Pressed Powder

Description

Almay Clear Complexion Pressed Powder is formulated for cosmetic use, presented in a compact form weighing 0.28 ounces (8.0 grams). This product is designed to provide a clear complexion while offering a pressed powder texture suitable for application on the skin.

Uses and Indications

This drug is indicated for the treatment of acne by helping to clear and prevent blemishes.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be covered with a thin layer of the medication. This application should be performed one to three times daily, depending on the severity of the condition and the clinical judgment of the healthcare professional. It is important to ensure that the entire affected area is adequately treated to achieve optimal therapeutic outcomes.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In such cases, it is recommended to limit the use to one topical acne treatment at a time to minimize the risk of irritation.

It is imperative to avoid contact with the eyes. Should accidental contact occur, the affected area must be flushed thoroughly with water to mitigate any potential adverse effects.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this medication should be aware that it is intended for external use only. The use of this product in conjunction with other topical acne medications may lead to skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate these effects.

Additionally, care should be taken to avoid contact with the eyes. Should contact occur, it is advised to flush the eyes thoroughly with water to alleviate any potential discomfort.

Drug Interactions

Concurrent use of topical acne medications may lead to skin irritation and dryness. It is advisable to limit the use to one topical acne medication at a time to minimize the risk of these adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and focus on a single treatment to manage their acne effectively. Monitoring for signs of skin irritation is recommended when initiating or adjusting therapy.

Packaging & NDC

Below are the non-prescription pack sizes of Almay Clear Complexion Pressed Powder (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Almay Clear Complexion Pressed Powder in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when recommending this product to elderly patients, as individual responses may vary. Monitoring for any adverse effects or sensitivities in this population is advisable, given the lack of targeted data.

Pregnancy

There is currently no information available regarding the use of Almay Clear Complexion Pressed Powder during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits of using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the potential risks associated with improper use and to take necessary precautions to ensure safety.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from direct sunlight and moisture.

To ensure safety, the product must be kept out of reach of children. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area 1 to 3 times daily. Clinicians should advise patients that the product is for external use only and caution them about the potential for skin irritation and dryness, particularly if used concurrently with other topical acne treatments. In the event of irritation, patients should limit the use to one topical acne medication at a time.

Patients are also instructed to avoid contact with the eyes; if contact occurs, they should flush the area thoroughly with water. Should bothersome dryness or peeling develop, it is recommended to reduce the frequency of application to once daily or every other day. Additionally, the medication should be kept out of reach of children, and in cases of ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Drug Information (PDF)

This file contains official product information for Almay Clear Complexion Pressed Powder, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)